The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.
about
Malignant pleural mesothelioma: predictors and stagingNovel immunotherapy clinical trials in malignant pleural mesothelioma.Diagnostic and prognostic biomarkers for malignant mesothelioma: an update.Volumetric assessment in malignant pleural mesothelioma.Clinical staging of malignant pleural mesothelioma: current perspectives.Malignant pleural mesothelioma: key determinants in tailoring the right treatment for the right patient.Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?A review of bevacizumab in the treatment of malignant pleural mesothelioma.Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience.Biomarkers in the prevention and follow-up of workers exposed to asbestos.Staging in the era of international databases: documented improvements with remaining challenges.Prospective registry database of patients with malignant mesothelioma: directions for a future Japanese registry-based lung cancer study.Proton beam therapy for malignant pleural mesothelioma.Malignant pleural mesothelioma-the impact of globalization on rare diseases.Quantitative Clinical Staging for Patients With Malignant Pleural Mesothelioma.Multimodality treatment of malignant pleural mesotheliomaThe eighth TNM classification for malignant pleural mesothelioma
P2860
Q33871571-443C02B7-8577-40A7-B65D-3F8B6C095C76Q33871577-29A20327-9563-4FE7-8A32-AB04B2C04360Q33890558-3ED9F9FA-5163-4609-AB95-9DD47A465F99Q39434239-83CD7494-2D7B-48CB-9101-6C92F686C1CDQ41522440-A28BC78A-34D8-4D68-9368-C170E7C405B7Q42362338-F996A063-BF48-4CB7-BB12-13013B474B5CQ47361459-DB6FAE6F-67F5-4F0F-BE63-56EE86664ECBQ47685374-409F9CD5-517D-4086-A797-D1EEE8306031Q49787880-E7DDE5F8-2BAE-43B8-9B94-9BAA3FB325EFQ52672882-5620A6EC-82EF-43F5-ACE0-58F6339EE094Q54991391-15B70182-4535-4FE4-AA75-91F8C6B8CC4EQ55026064-CE4754C7-08B7-46B8-A109-39B09CDAD81AQ55037897-B262D49A-56DC-4DA0-928D-0D3DA8D6E6F6Q55172221-ABA90F57-E072-4FC9-9732-BE59F8739728Q55318621-86D6D7FA-A9BA-428E-BF53-B8071A9FC200Q58580151-C8323952-BEF9-498C-B571-3363B7957290Q59137559-74B8B14C-A08A-450A-9892-A189C6542475
P2860
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The IASLC Mesothelioma Staging ...... tion for Pleural Mesothelioma.
@en
type
label
The IASLC Mesothelioma Staging ...... tion for Pleural Mesothelioma.
@en
prefLabel
The IASLC Mesothelioma Staging ...... tion for Pleural Mesothelioma.
@en
P2093
P50
P1476
The IASLC Mesothelioma Staging ...... tion for Pleural Mesothelioma.
@en
P2093
Andrea Billé
Charles F Thomas
David C Rice
Hasan F Batirel
Hedy L Kindler
Joseph Friedberg
Kari Chansky
Lynn Shemanski
Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions
Susana Cedres
P304
P356
10.1016/J.JTHO.2016.08.147
P577
2016-09-23T00:00:00Z